Authors:
Ruhnau, KJ
Meissner, HP
Finn, JR
Reljanovic, M
Lobisch, M
Schutte, K
Nehrdich, D
Tritschler, HJ
Mehnert, H
Ziegler, D
Citation: Kj. Ruhnau et al., Effects of 3-week oral treatment with the antioxidant thioctic acid (alpha-lipoic acid) in symptomatic diabetic polyneuropathy, DIABET MED, 16(12), 1999, pp. 1040-1043
Authors:
Garwood, J
Schnadelbach, O
Clement, A
Schutte, K
Bach, A
Faissner, A
Citation: J. Garwood et al., DSD-1-proteoglycan is the mouse homolog of phosphacan and displays opposing effects on neurite outgrowth dependent on neuronal lineage, J NEUROSC, 19(10), 1999, pp. 3888-3899
Authors:
Ziegler, D
Hanefeld, M
Rahnau, KJ
Hasche, H
Lobisch, M
Schutte, K
Kerum, G
Malessa, R
Citation: D. Ziegler et al., Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid - A 7-month multicenter randomized controlled trial (ALADIN III Study), DIABET CARE, 22(8), 1999, pp. 1296-1301